+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

From
United States Diabetes Market Report: 2024-2032 - Product Thumbnail Image

United States Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 139 Pages
  • United States
From
From
From
From
From
From
US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026 - Product Thumbnail Image

US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026

  • Report
  • August 2021
  • 50 Pages
  • United States
From
Type 2 Diabetes Treatment: Global Market Outlook - Product Thumbnail Image

Type 2 Diabetes Treatment: Global Market Outlook

  • Report
  • December 2022
  • 66 Pages
  • Global
From
Global Markets for Diabetes Therapeutics and Diagnostics - Product Thumbnail Image

Global Markets for Diabetes Therapeutics and Diagnostics

  • Report
  • August 2023
  • 336 Pages
  • Global
From
Global Markets for Insulin Drug and Delivery Technologies - Product Thumbnail Image

Global Markets for Insulin Drug and Delivery Technologies

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more